Tech Company M&A Transactions

Aspreva Pharmaceuticals Acquisition

On 10/18/2007, Aspreva Pharmaceuticals was bought by Galenica Group. The transaction price was $915.2 million.

Transaction Overview

Acquired By
Announced On
10/18/2007
Transaction Type
M&A
Amount
$915,200,000
M&A Terms
The acquisition will be paid with all cash.

Company Information

Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
106 Allen Rd.
Basking Ridge, NJ 07920
USA
Email Address
Not Recorded
Overview
Aspreva's novel business model, based on asset partnering, is revolutionizing pharmaceutical partnering and bringing desperately needed evidence-based medicines to underserved patient populations.
Profile
Aspreva Pharmaceuticals LinkedIn Company Profile
Social Media
Aspreva Pharmaceuticals Company Twitter Account
Company News
Aspreva Pharmaceuticals News
Facebook
Aspreva Pharmaceuticals on Facebook
YouTube
Aspreva Pharmaceuticals on YouTube

Management Team

Title
Name
Email & Social
Chief Financial Officer
Stephen Holmes
  Stephen Holmes LinkedIn Profile  Stephen Holmes Twitter Account  Stephen Holmes News  Stephen Holmes on Facebook
Controller
Katie Passalacqua
  Katie Passalacqua LinkedIn Profile  Katie Passalacqua Twitter Account  Katie Passalacqua News  Katie Passalacqua on Facebook
Controller
Karen Wilson
  Karen Wilson LinkedIn Profile  Karen Wilson Twitter Account  Karen Wilson News  Karen Wilson on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/18/2007: Social Media Networks venture capital transaction
Next: 10/18/2007: GridPoint venture capital transaction

 

Share this article

 


Where The Data Comes From

Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary